HK2 and neoplasm: Besides, when glycolysis in cellular metabolism is exuberant, HK2 can phosphorylate IκBa in tumor cells, leading to IκBa degradation and NF-κB activation-dependent increase in PD-L1 expression to evade tumor immunity (69).